[Source: World Newswire] – The University of California San Francisco (UCSF) is studying the effects the use of statin drugs may have on slowing the progression for MS victims. A research group studying MS patients, noticed a cholesterol-lowering drug, taken in the earliest stages of the disease, has the potential to lower the formation of new brain lesions.
Researchers are hopeful, though cautious. The study group was admittedly small, only 81 people. These individuals received 80 milligrams daily of atovastatin, also known as Lipitor, marketed by Pfizer, Inc.
For more information: Multiple Sclerosis New Study Suggests Statins Show Promise